Search research articles
Contact Us
Filters
Showing results (21-30 of 84) with videos related to
Page
of 9
Sort By:
The Journal of Biological Chemistry
|
May 11, 2010
The PEA-15 protein regulates autophagy via activation of JNK
Barbara C Böck, Katrin E Tagscherer, Anne Fassl, et al.
Journal of Neuro-Oncology
|
January 7, 2024
Combination drug screen identifies synergistic drug interaction of BCL-XL and class I histone deacetylase inhibitors in MYC-amplified medulloblastoma cells
Simon Zeuner, Johanna Vollmer, Romain Sigaud, et al.
Molecular Oncology
|
October 1, 2022
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma models through P-glycoprotein
Lisa Rösch, Sonja Herter, Sara Najafi, et al.
Journal of Neuro-Oncology
|
October 2, 2023
Class I HDAC inhibition reduces DNA damage repair capacity of MYC-amplified medulloblastoma cells
Johanna Vollmer, Jonas Ecker, Thomas Hielscher, et al.
Genes, Chromosomes & Cancer
|
November 26, 2008
Stepwise accumulation of distinct genomic aberrations in a patient with progressively metastasizing ependymoma
Till Milde, Stefan Pfister, Andrey Korshunov, et al.
Cells
|
April 30, 2021
Broad-Spectrum HDAC Inhibitors Promote Autophagy through FOXO Transcription Factors in Neuroblastoma
Katharina Körholz, Johannes Ridinger, Damir Krunic, et al.
Pharmacological Research
|
December 1, 2021
iTReX: Interactive exploration of mono- and combination therapy dose response profiling data
Dina ElHarouni, Yannick Berker, Heike Peterziel, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 30, 2020
Rapid In Vivo Validation of HDAC Inhibitor-Based Treatments in Neuroblastoma Zebrafish Xenografts
Jagoda K Wrobel, Sara Najafi, Simay Ayhan, et al.
Archives of Toxicology
|
June 28, 2018
The HDAC6/8/10 inhibitor TH34 induces DNA damage-mediated cell death in human high-grade neuroblastoma cell lines
Fiona R Kolbinger, Emily Koeneke, Johannes Ridinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 24, 2010
HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth
Till Milde, Ina Oehme, Andrey Korshunov, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 84) with videos related to
Sort By:
Page
of 9
The Journal of Biological Chemistry
|
May 11, 2010
The PEA-15 protein regulates autophagy via activation of JNK
Barbara C Böck, Katrin E Tagscherer, Anne Fassl, et al.
Journal of Neuro-Oncology
|
January 7, 2024
Combination drug screen identifies synergistic drug interaction of BCL-XL and class I histone deacetylase inhibitors in MYC-amplified medulloblastoma cells
Simon Zeuner, Johanna Vollmer, Romain Sigaud, et al.
Molecular Oncology
|
October 1, 2022
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma models through P-glycoprotein
Lisa Rösch, Sonja Herter, Sara Najafi, et al.
Journal of Neuro-Oncology
|
October 2, 2023
Class I HDAC inhibition reduces DNA damage repair capacity of MYC-amplified medulloblastoma cells
Johanna Vollmer, Jonas Ecker, Thomas Hielscher, et al.
Genes, Chromosomes & Cancer
|
November 26, 2008
Stepwise accumulation of distinct genomic aberrations in a patient with progressively metastasizing ependymoma
Till Milde, Stefan Pfister, Andrey Korshunov, et al.
Cells
|
April 30, 2021
Broad-Spectrum HDAC Inhibitors Promote Autophagy through FOXO Transcription Factors in Neuroblastoma
Katharina Körholz, Johannes Ridinger, Damir Krunic, et al.
Pharmacological Research
|
December 1, 2021
iTReX: Interactive exploration of mono- and combination therapy dose response profiling data
Dina ElHarouni, Yannick Berker, Heike Peterziel, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 30, 2020
Rapid In Vivo Validation of HDAC Inhibitor-Based Treatments in Neuroblastoma Zebrafish Xenografts
Jagoda K Wrobel, Sara Najafi, Simay Ayhan, et al.
Archives of Toxicology
|
June 28, 2018
The HDAC6/8/10 inhibitor TH34 induces DNA damage-mediated cell death in human high-grade neuroblastoma cell lines
Fiona R Kolbinger, Emily Koeneke, Johannes Ridinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 24, 2010
HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth
Till Milde, Ina Oehme, Andrey Korshunov, et al.
Page
of 9